Opposition to the introduction of tenders in France has convinced the country’s government to rethink its latest social security financing legislation. Off-patent industry association Gemme had warned that the plans posed an existential threat to the country’s generics industry and – along with current financial pressures – could lead to shortages and reduced competition.
Proposals to introduce tenders for medicines in France have been swiftly rolled back by the country’s government following pushback from the pharmaceutical industry.
The French government had included plans to introduce tenders in its initial draft social security legislation, or PLFSS, for 2023....
Also, Latest News From Europe, Canada, Saudi Arabia, Finland, China, And The US
Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.
Emerging CRISPR innovations, shifting regulatory landscapes, and rising partnerships are accelerating a paradigm shift in biotech pipelines
We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.
